Cargando…

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs

SIMPLE SUMMARY: In the last decades, many researchers produced promising data concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC). They are trying to tear the veil covering these orphan cancers, suggesting new therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prete, Alessandro, Matrone, Antonio, Gambale, Carla, Torregrossa, Liborio, Minaldi, Elisa, Romei, Cristina, Ciampi, Raffaele, Molinaro, Eleonora, Elisei, Rossella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267688/ https://www.ncbi.nlm.nih.gov/pubmed/34206867 http://dx.doi.org/10.3390/cancers13133200

Ejemplares similares

BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review
por: Matrone, Antonio, et al.
Publicado: (2023)

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients
por: Gambale, Carla, et al.
Publicado: (2023)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia
por: Prete, Alessandro, et al.
Publicado: (2021)

Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma
por: Mulè, Chiara, et al.
Publicado: (2021)

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency
por: Ramone, Teresa, et al.
Publicado: (2020)

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022)

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response
por: Campopiano, Maria Cristina, et al.
Publicado: (2023)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance
por: Ghirri, Arianna, et al.
Publicado: (2023)

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
por: Ciampi, Raffaele, et al.
Publicado: (2019)

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center
por: Prete, Alessandro, et al.
Publicado: (2021)

RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells
por: Romei, Cristina, et al.
Publicado: (2021)

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
por: Romei, Cristina, et al.
Publicado: (2018)

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities
por: Lorusso, Loredana, et al.
Publicado: (2021)

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
por: Minaldi, Elisa, et al.
Publicado: (2023)

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer
por: Molinaro, Eleonora, et al.
Publicado: (2019)

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
por: Matrone, Antonio, et al.
Publicado: (2019)

Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses
por: Matrone, Antonio, et al.
Publicado: (2022)

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
por: Elisei, Rossella, et al.
Publicado: (2019)

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test
por: Valerio, L., et al.
Publicado: (2023)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe
por: Barbaro, Daniele, et al.
Publicado: (2020)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
por: Romei, Cristina, et al.
Publicado: (2021)

Nutrition in Advanced Thyroid Cancer Patients
por: Agate, Laura, et al.
Publicado: (2022)

OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
por: Romei, Cristina, et al.
Publicado: (2012)

Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase?
por: Campopiano, Maria Cristina, et al.
Publicado: (2021)

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association
por: Elisei, Rossella, et al.
Publicado: (2013)

MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
por: Prete, Alessandro, et al.
Publicado: (2020)

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2020)

MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
por: Valerio, Laura, et al.
Publicado: (2020)

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions
por: Poma, Anello Marcello, et al.
Publicado: (2019)

Predictive Biomarkers in Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature
por: Orsolini, Francesca, et al.
Publicado: (2022)

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
por: Lorusso, L., et al.
Publicado: (2023)

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center
por: Vignali, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jmf1lmcd4g468uqcnantb14g62